company string | company_tickers list | cik string | sic string | office string | industry string | exchanges list | filing_type string | filing_date string | filing_accession_number string | filing_processed bool | parsed_toc_keys string | parsed_prospectus_summary_valid bool | parsed_prospectus_summary string | parsed_prospectus_summary_word_count int64 | parsed_risk_factors_valid bool | parsed_risk_factors string | parsed_risk_factors_word_count int64 | parsed_legal_matters_valid bool | parsed_legal_matters string | parsed_legal_matters_word_count int64 | filing_url string | filing_images list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-14 00:00:00 | 0001213900-23-048956 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023048956/fs12023a6_maisonsolu.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-13 00:00:00 | 0001213900-23-048627 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023048627/fs12023a5_maisonsolu.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-12 00:00:00 | 0001213900-23-048235 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023048235/fs12023a4_maisonsolutions.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-09 00:00:00 | 0001213900-23-047612 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023047612/fs12023a3_maisonsolutions.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-08 00:00:00 | 0001213900-23-047275 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023047275/ea179973-s1a2_maison.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1/A | 2023-06-02 00:00:00 | 0001213900-23-045855 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023045855/fs12023a1_maison.htm | [] |
Maison Solutions Inc. | [
"MSS"
] | 0001892292 | 5411 | 07 Trade & Services | Retail-Grocery Stores | [
"Nasdaq"
] | S-1 | 2023-05-22 00:00:00 | 0001213900-23-041999 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892292/000121390023041999/fs12023_maison.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2025-12-05 00:00:00 | 0001213900-25-118772 | true | PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; PRINCIPAL AND SELLING SHAREHOLDERS; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; DESCRIPTION OF SHARE CAPITAL; DESCRIPTION OF WARRANTS; TAXATION; PLAN OF DISTRIBUTION; EXPENSES OF THIS OFFERING; LEGAL MATTERS; EXPERTS; ENFORCEMENT OF CIVIL LIABILITIES; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/CMND_clearmind_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/CMND_clearmind_risk_factors.txt | 8,821 | false | ./parsed_sections/legal_matters/2025/CMND_clearmind_legal_matters.txt | 9,627 | https://www.sec.gov/Archives/edgar/data/0001892500/000121390025118772/ea0268001-f1a1_clearmind.htm | [
"https://www.sec.gov/Archives/edgar/data/0001892500/000121390025118772/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001892500/000121390025118772/image_002.jpg"
] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2025-11-26 00:00:00 | 0001213900-25-115501 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390025115501/ea0266607-f1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2025-09-19 00:00:00 | 0001213900-25-089545 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390025089545/ea0257746-f1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2024-02-07 00:00:00 | 0001213900-24-010714 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390024010714/ea192811-f1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2023-09-13 00:00:00 | 0001213900-23-076314 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023076314/ea185152-f1a2_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2023-07-25 00:00:00 | 0001213900-23-059737 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023059737/ea182267-f1a1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2023-07-17 00:00:00 | 0001213900-23-057457 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023057457/ea181877-f1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2023-03-31 00:00:00 | 0001213900-23-025046 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023025046/ea176152-f1a2_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2023-03-28 00:00:00 | 0001213900-23-023751 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023023751/ea175918-f1a1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2023-03-27 00:00:00 | 0001213900-23-023163 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390023023163/ea175194-f1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-11-14 00:00:00 | 0001213900-22-071802 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022071802/ea168586-f1a9_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-11-09 00:00:00 | 0001213900-22-070534 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022070534/ea168312-f1a8_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-11-04 00:00:00 | 0001213900-22-069110 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022069110/ea168007-f1a7_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-11-02 00:00:00 | 0001213900-22-068347 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022068347/ea167851-f1a6_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-10-26 00:00:00 | 0001213900-22-066551 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022066551/ea167556-f1a5_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-10-20 00:00:00 | 0001213900-22-065110 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022065110/ea167158-f1a4_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-10-06 00:00:00 | 0001213900-22-062505 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022062505/ea166639-f1a3_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-09-21 00:00:00 | 0001213900-22-057529 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022057529/ea165399-f1a2_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-08-18 00:00:00 | 0001213900-22-049331 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022049331/ea163000-f1a1_clearmind.htm | [] |
Clearmind Medicine Inc. | [
"CMND"
] | 0001892500 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2022-06-29 00:00:00 | 0001213900-22-035917 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001892500/000121390022035917/ea162124-f1_clearmind.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2025-11-28 00:00:00 | 0001213900-25-116002 | true | ABOUT THIS PROSPECTUS; FREQUENTLY USED TERMS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; COMMITTED EQUITY FINANCING; USE OF PROCEEDS; MARKET INFORMATION FOR COMMON STOCK AND DIVIDEND POLICY; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF ABPRO; DESCRIPTION OF NEW ABPRO’S BUSINESS; DIRECTORS AND EXECUTIVE OFFICERS; EXECUTIVE COMPENSATION; PRINCIPAL STOCKHOLDERS; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; DESCRIPTION OF CAPITAL STOCK; SELLING STOCKHOLDERS; PLAN OF DISTRIBUTION; UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS; EXPERTS; CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO FINANCIAL STATEMENTS | true | ./parsed_sections/prospectus_summary/2025/ABPWW_abpro_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/ABPWW_abpro_risk_factors.txt | 40,820 | false | null | 0 | https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/ea0266502-s1a1_abpro.htm | [
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_006.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_007.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_008.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_009.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_010.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_011.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_012.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_013.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_014.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_015.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_016.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_017.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_018.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_019.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_020.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_021.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_022.jpg",
"https://www.sec.gov/Archives/edgar/data/0001893219/000121390025116002/image_023.jpg"
] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-11-07 00:00:00 | 0001213900-25-107374 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000121390025107374/ea0264057-s1_abpro.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2025-06-06 00:00:00 | 0001213900-25-052118 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000121390025052118/ea0244342-s1a1_abpro.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-05-22 00:00:00 | 0001213900-25-046533 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000121390025046533/ea0242615-s1_abpro.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2025-02-07 00:00:00 | 0001213900-25-011397 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000121390025011397/ea0227005-s1a1_abpro.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2024-12-23 00:00:00 | 0001213900-24-111919 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000121390024111919/ea0224194-s1_abpro.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2022-01-06 00:00:00 | 0001193125-22-003638 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000119312522003638/d482235ds1a.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-12-20 00:00:00 | 0001193125-21-362526 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000119312521362526/d482235ds1a.htm | [] |
Abpro Holdings, Inc. | [
"ABPWW"
] | 0001893219 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2021-12-02 00:00:00 | 0001193125-21-346558 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893219/000119312521346558/d482235ds1.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2025-12-23 00:00:00 | 0001493152-25-029126 | true | null | true | null | 0 | true | ./parsed_sections/risk_factors/2025/RLEA_rubber_risk_factors.txt | 34,712 | false | null | 0 | https://www.sec.gov/Archives/edgar/data/0001893657/000149315225029126/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2025-12-22 00:00:00 | 0001493152-25-028855 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315225028855/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2025-04-10 00:00:00 | 0001641172-25-003531 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000164117225003531/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2025-02-13 00:00:00 | 0001493152-25-006429 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315225006429/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2024-08-02 00:00:00 | 0001493152-24-030114 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315224030114/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2024-04-19 00:00:00 | 0001493152-24-015400 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315224015400/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1 | 2024-02-23 00:00:00 | 0001493152-24-007667 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315224007667/forms-1.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2022-10-19 00:00:00 | 0001493152-22-028705 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315222028705/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2022-10-13 00:00:00 | 0001493152-22-028328 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315222028328/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2022-09-29 00:00:00 | 0001493152-22-027147 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315222027147/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2022-07-29 00:00:00 | 0001493152-22-020741 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315222020741/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1/A | 2022-03-03 00:00:00 | 0001493152-22-005978 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315222005978/forms-1a.htm | [] |
Rubber Leaf Inc | [
"RLEA"
] | 0001893657 | 3714 | 04 Manufacturing | Motor Vehicle Parts & Accessories | [
"OTC"
] | S-1 | 2021-11-15 00:00:00 | 0001493152-21-028420 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001893657/000149315221028420/forms-1.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2025-12-15 00:00:00 | 0001213900-25-121753 | true | Prospectus Summary; The Offering; Risk Factors; Cautionary Note Regarding Forward-Looking Statements; The Yorkville Transaction; Use of Proceeds; Capitalization; Selling Shareholder; Description of Share Capital; Description of American Depositary Shares; Plan of Distribution; Legal Matters; Experts; Enforceability of Civil Liabilities; Expenses; Where You Can Find Additional Information; Incorporation of Certain Information by Reference | true | ./parsed_sections/prospectus_summary/2025/SVREW_saverone_prospectus_summary.txt | 7,111 | true | ./parsed_sections/risk_factors/2025/SVREW_saverone_risk_factors.txt | 19,596 | false | ./parsed_sections/legal_matters/2025/SVREW_saverone_legal_matters.txt | 1,955 | https://www.sec.gov/Archives/edgar/data/0001894693/000121390025121753/ea0269420-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2025-07-01 00:00:00 | 0001213900-25-060400 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390025060400/ea0247743-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2025-03-31 00:00:00 | 0001213900-25-026309 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390025026309/ea0236279-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2025-03-31 00:00:00 | 0001213900-25-026272 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390025026272/ea0236276-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2024-12-06 00:00:00 | 0001213900-24-106549 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390024106549/ea0223580-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2024-07-26 00:00:00 | 0001013762-24-001331 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000101376224001331/ea0209982-f1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2023-12-13 00:00:00 | 0001213900-23-095391 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390023095391/ea189919-f1_saverone2014.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2023-06-07 00:00:00 | 0001213900-23-047178 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390023047178/ea179833-f1_saverone2014.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2023-01-17 00:00:00 | 0001213900-23-003045 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390023003045/ea171719-f1_saverone2014.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1/A | 2022-05-19 00:00:00 | 0001213900-22-028122 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022028122/ea160206-f1a5_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1/A | 2022-05-13 00:00:00 | 0001213900-22-026091 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022026091/ea159871-f1a4_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1/A | 2022-05-05 00:00:00 | 0001213900-22-024164 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022024164/ea159450-f1a3_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1/A | 2022-05-02 00:00:00 | 0001213900-22-022869 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022022869/ea159043-f1a2_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1/A | 2022-03-30 00:00:00 | 0001213900-22-016265 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022016265/ea156989-f1a1_saverone.htm | [] |
SaverOne 2014 Ltd. | [
"SVREW"
] | 0001894693 | 7371 | 06 Technology | Services-Computer Programming Services | [
"Nasdaq"
] | F-1 | 2022-03-07 00:00:00 | 0001213900-22-010909 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001894693/000121390022010909/ea156408-f1_saverone.htm | [] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-10-09 00:00:00 | 0001193125-25-236053 | true | Forward-Looking Statements; Prospectus Summary; The Offering; Risk Factors; Use of Proceeds; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Key Personnel of the Sponsor; Certain Relationships and Related Party Transactions; Description of the Shares; Description of Creation and Redemption of Shares; Material U.S. Federal Income Tax Consequences; ERISA and Related Considerations; Plan of Distribution; Legal Matters; Experts; Where You Can Find More Information | true | ./parsed_sections/prospectus_summary/2025/GSOL_grayscale_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/GSOL_grayscale_risk_factors.txt | 39,708 | false | ./parsed_sections/legal_matters/2025/GSOL_grayscale_legal_matters.txt | 53 | https://www.sec.gov/Archives/edgar/data/0001896677/000119312525236053/gsol_s-1_amendment_5.htm | [
"https://www.sec.gov/Archives/edgar/data/0001896677/000119312525236053/img178347045_0.jpg",
"https://www.sec.gov/Archives/edgar/data/0001896677/000119312525236053/img178347045_1.jpg",
"https://www.sec.gov/Archives/edgar/data/0001896677/000119312525236053/img178347045_2.jpg"
] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-09-26 00:00:00 | 0001193125-25-220733 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001896677/000119312525220733/gsol_s-1_amendment_4.htm | [] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-08-29 00:00:00 | 0001896677-25-000009 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001896677/000189667725000009/gsol_s-1_amendment_3.htm | [] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-07-31 00:00:00 | 0000950170-25-100875 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001896677/000095017025100875/gsol_s-1_amendment_2.htm | [] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-06-13 00:00:00 | 0000950170-25-086278 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001896677/000095017025086278/gsol_s-1_amendment_1.htm | [] |
Grayscale Solana Staking ETF | [
"GSOL"
] | 0001896677 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1 | 2025-04-04 00:00:00 | 0000950170-25-050885 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001896677/000095017025050885/gsol_s-1.htm | [] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1/A | 2026-01-23 00:00:00 | 0001628280-26-003317 | true | About this Prospectus; Industry and Market Data; Prospectus Summary; Risk Factors; Cautionary Note Regarding Forward-Looking Statements; Use of Proceeds; Capitalization; Dividend Policy; Dilution; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters; Management; Executive Compensation; Security Ownership of Certain Beneficial Owners and Management; Transactions With Related Persons, Promoters and Certain Control Persons and Director Independence; Selling Shareholders; Description of Securities to be Registered; Material US Federal Income Tax Considerations for Non-US Holders of Common Stock; Plan of Distribution; Legal Matters; Experts; Where You Can Find More Information; Index to Consolidated Financial Statements | false | ./parsed_sections/prospectus_summary/2026/CIK0001903508_public_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/CIK0001903508_public_risk_factors.txt | 11,903 | false | ./parsed_sections/legal_matters/2026/CIK0001903508_public_legal_matters.txt | 47 | https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/pphc-sx1a5.htm | [
"https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/pphclogo.jpg",
"https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/business1b.jpg",
"https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/business2a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/business3b.jpg",
"https://www.sec.gov/Archives/edgar/data/0001903508/000162828026003317/mnblumlogo.jpg"
] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1/A | 2026-01-20 00:00:00 | 0001628280-26-002555 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903508/000162828026002555/pphc-sx1a4.htm | [] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1/A | 2026-01-09 00:00:00 | 0001628280-26-001527 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903508/000162828026001527/pphc-sx1a3withrestatement.htm | [] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1/A | 2025-11-12 00:00:00 | 0001628280-25-051486 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903508/000162828025051486/pphc-sx1a2.htm | [] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1/A | 2025-10-21 00:00:00 | 0001628280-25-045728 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903508/000162828025045728/pphc-sx1a1.htm | [] |
Public Policy Holding Company, Inc. | [] | 0001903508 | 8742 | 07 Trade & Services | Services-Management Consulting Services | [] | S-1 | 2025-10-10 00:00:00 | 0001628280-25-044817 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903508/000162828025044817/pphc-sx1.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1 | 2025-12-23 00:00:00 | 0001213900-25-125477 | true | ABOUT THIS PROSPECTUS; CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; USE OF PROCEEDS; SELLING SECURITYHOLDER; DESCRIPTION OF CAPITAL STOCK; PLAN OF DISTRIBUTION (CONFLICT OF INTEREST); INFORMATION INCORPORATED BY REFERENCE; WHERE YOU CAN FIND MORE INFORMATION; LEGAL MATTERS; EXPERTS | true | ./parsed_sections/prospectus_summary/2025/TBH_brag_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/TBH_brag_risk_factors.txt | 3,710 | false | ./parsed_sections/legal_matters/2025/TBH_brag_legal_matters.txt | 5,031 | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025125477/ea0270422-s1_braghouse.htm | [
"https://www.sec.gov/Archives/edgar/data/0001903595/000121390025125477/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001903595/000121390025125477/image_002.jpg"
] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2025-09-23 00:00:00 | 0001213900-25-090296 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025090296/ea0257960-s1a1_brag.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1 | 2025-08-11 00:00:00 | 0001213900-25-074419 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025074419/ea0251980-s1_brag.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2025-02-11 00:00:00 | 0001213900-25-012154 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025012154/ea0204930-10.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2025-02-04 00:00:00 | 0001213900-25-009640 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025009640/ea0204930-08.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2025-01-13 00:00:00 | 0001213900-25-003044 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390025003044/ea0204930-07.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2024-12-03 00:00:00 | 0001213900-24-104751 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390024104751/ea0204930-06.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2024-08-05 00:00:00 | 0001213900-24-064895 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390024064895/ea0204930-04.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1/A | 2024-07-10 00:00:00 | 0001213900-24-060509 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390024060509/ea0204930-02.htm | [] |
Brag House Holdings, Inc. | [
"TBH"
] | 0001903595 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | S-1 | 2024-06-18 00:00:00 | 0001213900-24-053492 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001903595/000121390024053492/ea0204930-01.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1/A | 2026-01-27 00:00:00 | 0001213900-26-008321 | true | PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS; MARKET AND INDUSTRY DATA; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; DILUTION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE COMPENSATION; CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS; PRINCIPAL STOCKHOLDERS; DESCRIPTION OF CAPITAL STOCK; SHARES ELIGIBLE FOR FUTURE SALE; MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF OUR COMMON STOCK; UNDERWRITING; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; Index to Consolidated Financial Statements | false | ./parsed_sections/prospectus_summary/2026/CIK0001906425_invea_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2024/CIK0001906425_invea_risk_factors.txt | 46,371 | false | ./parsed_sections/legal_matters/2026/CIK0001906425_invea_legal_matters.txt | 28,132 | https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/ea0231890-10.htm | [
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/tinvea_logo.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/tcover_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_006.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_007.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_008.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_009.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_010.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_011a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_012a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_013a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_014.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_015.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_023a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_024a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_025a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_026a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_027a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_28.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_029.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_016a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_017a.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_018.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_030.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_019.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_020.jpg",
"https://www.sec.gov/Archives/edgar/data/0001906425/000121390026008321/timage_022.jpg"
] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1/A | 2026-01-23 00:00:00 | 0001213900-26-007338 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000121390026007338/ea0231890-08.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1/A | 2026-01-07 00:00:00 | 0001213900-26-001947 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000121390026001947/ea0231890-07.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1 | 2025-12-15 00:00:00 | 0001213900-25-121387 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000121390025121387/ea0231890-05.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1/A | 2024-01-26 00:00:00 | 0001104659-24-007237 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000110465924007237/tm2321493-16_s1a.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1/A | 2024-01-12 00:00:00 | 0001104659-24-003696 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000110465924003696/tm2321493-10_s1a.htm | [] |
Invea Therapeutics, Inc | [] | 0001906425 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [] | S-1 | 2023-10-20 00:00:00 | 0001104659-23-110477 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001906425/000110465923110477/tm2321493-8_s1.htm | [] |
QQJ Inc. | [] | 0001907197 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [] | F-1/A | 2025-12-23 00:00:00 | 0001213900-25-125411 | true | PROSPECTUS SUMMARY; THE OFFERING; SUMMARY FINANCIAL DATA; RISK FACTORS; DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS; ENFORCEABILITY OF CIVIL LIABILITIES; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; DILUTION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS; INDUSTRY; BUSINESS; REGULATIONS; MANAGEMENT; PRINCIPAL SHAREHOLDERS; RELATED PARTY TRANSACTIONS; DESCRIPTION OF SHARE CAPITAL; SHARES ELIGIBLE FOR FUTURE SALE; TAXATION; UNDERWRITING; EXPENSES RELATING TO THIS OFFERING; LEGAL MATTERS; EXPERTS; INTERESTS OF NAMED EXPERTS AND COUNSEL; DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION; WHERE YOU CAN FIND ADDITIONAL INFORMATION; FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/CIK0001907197_qqj-inc_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/CIK0001907197_qqj-inc_risk_factors.txt | 41,164 | false | ./parsed_sections/legal_matters/2025/CIK0001907197_qqj-inc_legal_matters.txt | 6,844 | https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/ea0208126-03.htm | [
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tqqj_logo.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tflowchart_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tflowchart_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tbarchart_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tbarchart_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tbarchart_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/tflowchart_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_006.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_007.jpg",
"https://www.sec.gov/Archives/edgar/data/0001907197/000121390025125411/timage_008.jpg"
] |
QQJ Inc. | [] | 0001907197 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [] | F-1/A | 2025-04-15 00:00:00 | 0001213900-25-032169 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001907197/000121390025032169/ea0208126-02.htm | [] |
QQJ Inc. | [] | 0001907197 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [] | F-1/A | 2024-06-28 00:00:00 | 0001213900-24-057154 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001907197/000121390024057154/ea0208126-01.htm | [] |
QQJ Inc. | [] | 0001907197 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [] | F-1 | 2024-02-07 00:00:00 | 0001213900-24-011016 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001907197/000121390024011016/ff12024_qqjinc.htm | [] |
Klotho Neurosciences, Inc. | [
"KLTOW"
] | 0001907223 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-12-05 00:00:00 | 0001213900-25-118825 | true | Prospectus Summary; Risk Factors; Forward Looking Statements; Use of Proceeds; Plan of Distribution; Certain Relationships and Related Transactions; Selling Stockholders; Changes in and Disagreements with Accountants on Accounting and Financial Disclosure; Experts; Legal Proceedings; Legal Matters; Incorporation by Reference; Where You Can Find More Information | false | ./parsed_sections/prospectus_summary/2025/KLTOW_klotho_prospectus_summary.txt | 128 | false | ./parsed_sections/risk_factors/2025/KLTOW_klotho_risk_factors.txt | 16,560 | false | ./parsed_sections/legal_matters/2025/KLTOW_klotho_legal_matters.txt | 2,395 | https://www.sec.gov/Archives/edgar/data/0001907223/000121390025118825/ea0268254-s1_klotho.htm | [] |
Klotho Neurosciences, Inc. | [
"KLTOW"
] | 0001907223 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-01-30 00:00:00 | 0001213900-25-008318 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001907223/000121390025008318/ea0228844-s1_klotho.htm | [] |
Klotho Neurosciences, Inc. | [
"KLTOW"
] | 0001907223 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2024-09-13 00:00:00 | 0001213900-24-078244 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001907223/000121390024078244/ea0214414-s1a1_anewmedical.htm | [] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.